Archive | Video Reports

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the benefits of immunotherapy, specifically the combination of the CTLA-4 inhibitoripilimumab (Yervoy) and the PD-1 inhibitor nivolumab (Opdivo), in melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Neoadjuvant and Frontline Studies Guide Malignant Melanoma Treatment

The development of targeted therapies and immune checkpoint inhibitors has changed the management of malignant melanoma, providing safer and more effective treatment options and improving outcomes for many patients with this malignancy.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Dr. Flaherty on Second-Line Therapy for BRAF-Mutant Melanoma

Keith T. Flaherty, MD, professor of medicine, Harvard Medical School, director, Henri and Belinda Termeer Center for Targeted Therapy, director of clinical research, Massachusetts General Hospital, discusses treatment beyond frontline therapy for patients with BRAF-mutant relapsed/refractory melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Dr. Atkins on CA209-004 Trial Results in Advanced Melanoma

Michael B. Atkins, MD, deputy director, Georgetown-Lombardi Comprehensive Cancer Center, discusses results from the CA209-004 trial, which was a phase I study analyzing patients with advanced, unresectable melanoma treated with nivolumab (Opdivo) plus ipilimumab (Yervoy).

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports